Study title: Fetal Toxoplasmosis: Outcome of Pregnancy and Infant Follow-Up After In Utero Treatment.Hohlfeld P; Daffos F; Thulliez P; Aufrant C; Couvreur J; MacAleese J J.Pediatr. 115, No. 5, Pt. 1, 765-69, 1989
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Parasitic Diseases [C03] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: SPIRAMYCIN | |||||
ATC code: J01FA02 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |